Water → 4-{[(3S)-3-methyl-4-(2-pyridinylcarbonyl)-1-piperazinyl]sulfonyl}benzonitrile

HRID 41316

반응식

HRID 41316 반응식
Cl.Cl.[CH3:3][C@H:4]1[CH2:9][NH:8][CH2:7][CH2:6][N:5]1[C:10]([C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][N:13]=1)=[O:11].CCN(C(C)C)C(C)C.[C:27]([C:29]1[CH:34]=[CH:33][C:32]([S:35](Cl)(=[O:37])=[O:36])=[CH:31][CH:30]=1)#[N:28].O>C(Cl)Cl>[CH3:3][C@@H:4]1[N:5]([C:10]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][N:13]=2)=[O:11])[CH2:6][CH2:7][N:8]([S:35]([C:32]2[CH:31]=[CH:30][C:29]([C:27]#[N:28])=[CH:34][CH:33]=2)(=[O:37])=[O:36])[CH2:9]1

참가 물질

6

반응물 4

HCID 962WaterHCID 394974-Cyanobenzenesulfonyl chlorideHCID 81531DiisopropylethylamineHCID 67222743(2S)-2-methyl-1-(2-pyridinylcarbonyl)piperazine dihydrochloride

생성물 1

HCID 446119604-{[(3S)-3-methyl-4-(2-pyridinylcarbonyl)-1-piperazinyl]sulfonyl}benzonitrile수율 50.8%

시약·촉매·용매 1

HCID 6344Dichloromethane용매2회

실험 절차

To a solution of (2S)-2-methyl-1-(2-pyridinylcarbonyl)piperazine dihydrochloride (Description 16) (71 mg, 0.255 mmol) in DCM (3 ml) was added DIPEA (0.183 ml, 1.046 mmol) at room temperature and to it was slowly added 4-cyanobenzenesulfonyl chloride (56.6 mg, 0.281 mmol) and the resultant mixture then stirred for 3 h. 5 ml of water and 5 ml of DCM were added and the organic layer separated with a phase separation cartridge and then evaporated under vacuum. The crude material (120 mg) was purified via Biotage (12M silica column) using a gradient [i-hex/EtOAc] ([90/10] to [40/60]). The desired fractions were then collected and concentrated to dryness giving the title compound (48 mg) as a white solid.

후처리

  1. customthe organic layer separated with a phase separation cartridge
  2. customevaporated under vacuum
  3. customThe crude material (120 mg) was purified via Biotage (12M silica column)
  4. customThe desired fractions were then collected
  5. concentrationconcentrated to dryness

출처 및 근거

ORD 기록
ord-dc0910905023484a84df89cc4a67cb1f
출처 데이터셋
uspto-grants-2013_09
특허 번호
US08530478B2

연결된 노트

불러오는 중…